Health
CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.
Covid Potential for Brain Damage, According to Scientists
A study conducted by researchers at University College London (UCL) reported 43 cases of patients diagnosed with Covid experiencing temporary brain damage. The scientists warned that new evidence suggests potential issues of severe neurological complications, like...
Over 200 Scientists Claim Covid Is Airborne According to NYT
239 scientists from 32 countries have submitted an open letter with mounting evidence to the WHO that the Covid can be spread through the air. The WHO has stated that only after medical procedures that produce aerosols, or droplets smaller than 5 microns is the virus...
A Quicker Transition to Digitalizing Healthcare in the European Union
European Union Nations agree to accelerate their digital transformation as an ‘essential component of the EU’s response to the economic crisis generated by the COVID-19 pandemic.’ The impact of Covid on the European Union’s diverse healthcare systems has led EU...
Early Potential in Human Trials for Covid Vaccine
BioNTech, and Pfizer have partnered to produce one of the 17 Covid vaccines currently in development. The vaccine has shown promising early-stage human trials among 24 participants, alongside other pharmaceutical companies like Moderna, Inovio Pharmaceuticals,...
Gilead Sets Price for Covid Treatment Remdesivir
Gilead Sciences, the biotech company based out of California that created one of the first original treatments for Covid, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...
Covid Infection Rates Could Be 10 Times Higher Than Reports Show
The Center for Disease Control (CDC) reported last night (6/24) that the actual number of patients in the United States infected with Covid could potentially be ten times higher. The estimate comes from a serology test that is used to determine if an individual has...
Clinical Trials in Latin America: Digging in for Long Term Growth
With so many cultures, populations, and regulatory variability in Latin America (LATAM), pinning it down to a specific cultural or business practice can be a more sophisticated process than it is in other regions. For clinical trials, Latin America is a hotbed of...
Gilead More than Doubles Original Courses Expectation for Remdesivir to Fight Covid
Gilead announced today (6/22) that its expectation for supply of remdesivir to fight Covid increased from 1 million to exceed 2 million by the end of 2020. Remdesivir is on the forefront of fighting the pandemic, helping shorten the length of hospital recovery times...
The Doctor Will See You Now: Delivering Telehealth Solutions Across Language Barriers
As a global crisis, the COVID-19 pandemic has called on interpreters and translators to step forward and contribute their linguistic expertise to worldwide aid efforts on numerous fronts, including telehealth. As well as supporting clinical trials, the past several...
Dexamethasone and COVID-19: The Breakthrough Steroid Saving Severely Ill Patients
Dexamethasone, a cheap and widely used steroid used to reduce inflammation for patients afflicted with arthritis, asthma, some skin conditions, and more, has been recognized as a breakthrough treatment from severely ill COVID-19 patients. When in use, it has shown to...
Categories
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com